Synapse loss may be a minor contributor to decreased regional cerebral blood flow in Alzheimer disease

Dementia and Geriatric Cognitive Disorders

Volumn 15, Issue 2, 2003, Pages 72-78

  Bigio, Eileen H ^a   Reisch, Joan S ^b   White III, Charles L ^b   Satumtira, Sivapong ^b   Sontag, Estelle ^b   Bonte, Frederick J ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Cerebral blood flow, regional; SPECT; Synapse; Synaptophysin

Indexed keywords

SYNAPTOPHYSIN; XENON;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN TISSUE; CADAVER; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNIQUE; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; SYNAPSES; SYNAPTOPHYSIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037234977     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067970     Document Type: Article

References (22)

1. Chui HC: Dementia: A review emphasizing clinico-pathologic correlation and brain-behavior relationships. Arch Neurol 1989;46:806-814.
2. Bonte FJ, Tintner R, Weiner MF, Bigio EH, White CL 3rd: Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology 1993;186:361-365.
3. Bonte FJ, Weiner MF, Bigio EH, White CL 3rd: Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology 1997;202:793-797.
4. Davies CA, Mann DMA, Sumpter PQ, Yates PO: A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. Neurol Sci 1987;78:151-164.
5. DeKosky ST, Scheff SW: Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Neurol 1990;27:457-464.
6. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-580.
7. Masliah E, Ellisman M, Carragher B, Mallory M, Young S, Hansen L, DeTeresa R, Terry RD: Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J Neuropathol Exp Neurol 1992;51:404-414.
8. Lassman H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk W, Seitelberger F, Winkler H: Synaptic pathology in Alzheimer's disease: Immunological data for markers of synaptic and large densecore vesicles. Neuroscience 1992;46:1-8.
9. Blennow K, Bogdanovic N, Alafuzoff I, Ekman R, Davidsson P: Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm 1996;103:603-618.
10. DeKosky ST, Scheff SW, Styren SD: Structural correlates of cognition in dementia: Quantification and assessment of synapse change. Neurodegeneration 1996;5:417-421.
11. Terry RD: The cytoskeleton in Alzheimer disease. J Neural Transm Suppl 1998;53:141-145.
12. White CL 3rd, Tripp P, Eagan KP, Welch E, Stiegler A, Bigio EH: Quantification of synapse density in Alzheimer disease neocortex using a two-site enzyme-linked immunosorbant assay (ELISA) and antibodies to synaptophysin. J Neuropathol Exp Neurol 1995;54:430.
13. Schlaf G, Salje C, Poethke R, Felgenhauer K, Mäder M: A novel enzyme-linked immunosorbent assay for determination of synaptophysin as compared with other quantification procedures. J Neuroimmunol 1996;67:59-65.
14. Schlaf G, Göddecke M, Wolff JR, Felgenhauer K, Mäder M: Large-scale purification of synaptophysin and quantification with a newly established enzyme-linked immunosorbent assay. Biol Chem 1996;377:591-597.
15. Zhan SS, Beyreuther K, Schmitt HP: Quantitative assessment of the synaptophysin immunoreactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 1993;4:66-74.
16. Liu S, Brun A: Synaptophysin immunoreactivity is stable 36 h postmortem. Dementia 1995;6:211-217.
17. Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL 3rd: Synapse loss is greater in presenile than senile onset Alzheimer disease: Implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 2002;28/3:218-227.
18. Bigio EH, Vono MB, Satumtira S, Adamson J, Sontag E, Hynan LS, White CL 3rd, Baker M, Hutton M: Cortical synapse loss in progressive supranuclear palsy. J Neuropathol Exp Neurol 2001;60:403-410.
19. Lipton AM, Cullum CM, Satumtira S, Sontag E, Hynan LS, White CL 3rd, Bigio EH: Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol 2001;58:1233-1239.
20. White CL 3rd, Welch EM, Brown DR, Speciale SG, Sontag E: Production and characterization of a recombinant synaptophysin fragment suitable for use as a standard in immunoassays. J Neuropathol Exp Neurol 1997;56:608.
21. Calhoun ME, Jucker M, Martin LJ, Thinakaran G, Price DL, Mouton PR: Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol 1996;25:821-828.
22. Masliah E, Mallory M, Hansen L, DeTeresa R, Terry RD: Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993;43:192-197.